APC Anti-Human CD19 Antibody[4G7]

Introducing the APC Anti-Human CD19 Antibody [4G7], a highly reliable and efficient solution for immunophenotyping applications. This product is designed to accurately detect and quantify CD19 expression in human samples, enabling researchers and clinicians to gain valuable insights into various diseases and conditions.

With a generous size of 200 tests, this antibody offers an ample supply to meet the demands of extensive experimentation and analysis. Its superior quality ensures consistent and reproducible results, allowing for precise and reliable data interpretation.

The APC Anti-Human CD19 Antibody [4G7] is meticulously developed using advanced technology and rigorous quality control measures. This guarantees exceptional specificity and sensitivity, enabling the detection of even low levels of CD19 expression. Its high affinity for the CD19 antigen ensures optimal binding, facilitating accurate identification and characterization of CD19-positive cells.

This antibody is compatible with a wide range of immunofluorescence techniques, including flow cytometry, immunohistochemistry, and immunocytochemistry. Its exceptional performance across multiple platforms makes it a versatile tool for various research and diagnostic applications.

Furthermore, the APC Anti-Human CD19 Antibody [4G7] exhibits excellent stability, ensuring long shelf life and consistent performance over time. Its user-friendly formulation simplifies the experimental workflow, allowing for seamless integration into laboratory protocols.

In summary, the APC Anti-Human CD19 Antibody [4G7] is a highly reliable and efficient solution for immunophenotyping applications. With its generous size of 200 tests, exceptional specificity, and compatibility with various techniques, this antibody empowers researchers and clinicians to advance their understanding of CD19 expression in human samples. Trust in its superior quality and performance to unlock valuable insights into diseases and conditions, ultimately contributing to improved patient care and outcomes.